Indications

Mesh Heading Maximum Phase Mesh ID Reference
Fatty Liver 3 D005234 ClinicalTrials
Tobacco Use Disorder 3 D014029 ClinicalTrials
Attention Deficit Disorder with Hyperactivity 3 D001289 ClinicalTrials
Dry Eye Syndromes 3 D015352 ClinicalTrials
Renal Insufficiency, Chronic 3 D051436 ClinicalTrials
Acquired Immunodeficiency Syndrome 3 D000163 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Premature Birth 3 D047928 ClinicalTrials
Coronary Artery Disease 3 D003324 ClinicalTrials
Depressive Disorder 3 D003866 ClinicalTrials
Coronary Disease 3 D003327 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Periodontitis 2 D010518 ClinicalTrials
Depressive Disorder, Major 2 D003865 ClinicalTrials
Nutrition Disorders 2 D009748 ClinicalTrials
Sjogren's Syndrome 2 D012859 ClinicalTrials
Multiple Myeloma 2 D009101 ClinicalTrials
Child Development Disorders, Pervasive 2 D002659 ClinicalTrials
Peripheral Arterial Disease 2 D058729 ClinicalTrials
Epilepsy 2 D004827 ClinicalTrials
Immunologic Deficiency Syndromes 2 D007153 ClinicalTrials
Bipolar Disorder 2 D001714 ClinicalTrials
Anemia, Sickle Cell 2 D000755 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 2 D015451 ClinicalTrials
Paraproteinemias 2 D010265 ClinicalTrials
Non-alcoholic Fatty Liver Disease 1 D065626 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials
Pregnancy 1 D011247 ClinicalTrials
Infertility, Male 1 D007248 ClinicalTrials
Multiple Sclerosis 1 D009103 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 329042-31-1
ChEMBL CHEMBL4298065
FDA SRS 71M78END5S